Capital Fund Management (CFM)’s Imperva, Inc. IMPV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-76,371
| Closed | -$4.25M | – | 2268 |
|
|
2018
Q4 | $4.25M | Buy |
+76,371
| New | +$4.15M | 0.04% | 567 |
|
|
2018
Q2 | – | Sell |
-13,900
| Closed | -$602K | – | 2394 |
|
|
2018
Q1 | $602K | Buy |
+13,900
| New | +$624K | ﹤0.01% | 1395 |
|
|
2017
Q4 | – | Sell |
-87,951
| Closed | -$3.82M | – | 2074 |
|
|
2017
Q3 | $3.82M | Sell |
87,951
-26,000
| -23% | -$1.19M | 0.03% | 605 |
|
|
2017
Q2 | $5.45M | Buy |
113,951
+52,559
| +86% | +$2.45M | 0.04% | 447 |
|
|
2017
Q1 | $2.52M | Buy |
+61,392
| New | +$2.56M | 0.02% | 672 |
|
|
2016
Q4 | – | Sell |
-46,000
| Closed | -$2.47M | – | 1958 |
|
|
2016
Q3 | $2.47M | Buy |
+46,000
| New | +$2.13M | 0.02% | 685 |
|
|
2016
Q1 | – | Sell |
-56,650
| Closed | -$3.59M | – | 2002 |
|
|
2015
Q4 | $3.59M | Buy |
+56,650
| New | +$3.86M | 0.04% | 525 |
|
|
2014
Q3 | – | Sell |
-10,700
| Closed | -$280K | – | 1948 |
|
|
2014
Q2 | $280K | Buy |
+10,700
| New | +$276K | ﹤0.01% | 1453 |
|
Capital Fund Management (CFM)'s IMPV Position: Q1 2019 in Review
Capital Fund Management (CFM) sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 76,371 shares — an estimated $4.25M sold.
Capital Fund Management (CFM) first reported a position in IMPV in Q2 2014 and held it in 8 quarters. The position peaked at $5.45M in Q2 2017. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.
- Capital Fund Management (CFM) reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
- Capital Fund Management (CFM) sold 76,371 Imperva, Inc. shares in Q1 2019, an estimated $4.25M.
- Capital Fund Management (CFM) first reported a position in Imperva, Inc. in Q2 2014 and held it in 8 quarters.
- Capital Fund Management (CFM)'s Imperva, Inc. position peaked at $5.45M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.
Based on Capital Fund Management (CFM)'s 13F filing for Q1 2019, filed 13 May 2019.